GlassScriptPhysician profile
Alan J Discont
NPI 1063463305
$1,859.74
in general payments reported to CMS, 2019-2025
35 companies · $13.88 in 2025
The $13.88 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $311 · 2021: $240 · 2022: $317 · 2023: $223 · 2024: $470 · 2025: $13.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654 · Debt Forgiveness: $53.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.67 |
| Debt Forgiveness | $53.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $252.73 | 2020-2024 | Cmf |
| Horizon Therapeutics Plc | $181.68 | 2019-2023 | Krystexxa |
| Forthright Medical - Az, LLC | $155.88 | 2024 | |
| Organogenesis INC. | $150.11 | 2019-2022 | |
| Orthofix Medical, INC. | $132.76 | 2021-2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $104.70 | 2024 | |
| Stryker Corporation | $81.82 | 2021-2023 | Augment Injectable, Ortholoc 3di, Easyfuse |
| Allergan, INC. | $81.15 | 2020 | |
| Bioventus LLC | $60.86 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $56.24 | 2021-2023 | Nuzyra |
| Abbvie INC. | $46.79 | 2021-2022 | |
| Sandoz INC. | $43.10 | 2019 | |
| Ibsa Pharma INC. | $42.18 | 2023-2024 | Tirosint, Tirosint, Licart |
| Nabriva Therapeutics, Plc | $40.58 | 2021-2022 | |
| Kerecis Limited | $40.11 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $34.80 | 2024 | Qutenza |
| Grt US Holding, INC. | $33.12 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $30.25 | 2022 | |
| Kci USA, INC. | $30.21 | 2020 | |
| Melinta Therapeutics, LLC | $27.22 | 2019-2020 | |
| Smith+Nephew, INC. | $26.75 | 2024 | Grafix |
| Nalu Medical, INC. | $18.71 | 2021 | |
| Amgen INC. | $17.46 | 2024 | Krystexxa |
| Rikco International, LLC | $17.35 | 2019 | |
| Glenmark Therapeutics INC. | $16.00 | 2019 | |
| Pfizer INC. | $15.80 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $15.32 | 2019 | |
| Innovation Technologies INC | $15.05 | 2024 | Irrisept |
| Bsn Medical INC | $14.17 | 2019 | |
| Celularity INC. | $14.00 | 2019 | |
| Medela LLC | $13.68 | 2022 | |
| Tactile Systems Technology INC | $12.89 | 2020 | |
| Reprise Biomedical, INC. | $12.69 | 2024 | Miro3d |
| Assertio Therapeutics, INC. | $11.91 | 2019 | |
| Merck Sharp & Dohme LLC | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Discont listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.